NASH-TAG Conference 2017
Event Date: January 5 - 7, 2017
Event Location: Park City Marriott, 1895 Sidewinder Drive, Park City, UT 84060
Learn from world-changing thinkers and innovators in NASH (non-alcoholic steatohepatitis) and Fibrosis at NASH-TAG 2017
The NASH-TAG Conference is designed to bring together clinicians and researchers in academia and the pharmaceutical industry for a focused interactive educational update highlighting the most relevant advances and challenges in NASH and liver fibrosis. NASH-TAG 2017 will take place over two days providing attendees an understanding of current and future directions in procedures, prospects and challenges in drug discovery and development for both NASH and liver fibrosis. Internationally renowned faculty will assist in the development of the educational content and will serve as faculty at the conference.
Non-alcoholic fatty liver disease (NAFLD) is one of the types of fatty liver which occurs when fat is deposited (steatosis) in the liver due to causes other than excessive alcohol use. NAFLD is the most common liver disorder in developed countries and is related to insulin resistance and metabolic syndrome.
Non-alcoholic steatohepatitis (NASH) is the most extreme form of NAFLD, and is regarded as a major cause of cirrhosis of the liver of unknown cause.